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Background
In the middle of the 20th century, chemical neurotrans-
mission in the brain was still an issue of debate. In this
context, research on Parkinson's disease played a signifi-
cant role, as it lead beyond the simple identification of a
neurotransmitter to the formation of an articulate clinico-
pathological model and a rational therapeutic approach.
Discussion
A. Carlsson was the first to suggest a neurotransmitting
role for dopamine in 1955; a few years later, his team
observed the great dopamine concentrations in the basal
ganglia. The clinical implications of this finding were
soon realized – it was already known since the beginning
of the century that the basal ganglia are involved in Par-
kinson's disease. The studies of O. Hornykiewicz and T.
Sourkes suggested a dopamine deficiency in Parkinson's
patients, and in the mid-1960's considerable evidence was
gathering in favor of the existence of a nigrostriatal
dopaminergic pathway, involved in the regulation of
motility. The renewal of the pharmaceutical treatment of
the disease followed closely: Hornykiewicz and Birkmayer
(1960), and almost concurrently Sourkes and Barbeau
(1962), conceived the idea of administering L-DOPA in
patients with Parkinson's disease, with spectacular results.
The treatment of Parkinson's disease evolved in the fol-
lowing years, with optimisation of administration regi-
mens by Cotzias et al (1967), as well as with the
introduction of decarboxylase inhibitors. In the mid-
1960's the concept of dopamine as a neurotransmitter
had reached mainstream status, and the nigrostriatal path-
way had become a model for the study of central synapses.
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